GB0904044D0 - The treatment of inflammatory disorders and pain - Google Patents

The treatment of inflammatory disorders and pain

Info

Publication number
GB0904044D0
GB0904044D0 GBGB0904044.5A GB0904044A GB0904044D0 GB 0904044 D0 GB0904044 D0 GB 0904044D0 GB 0904044 A GB0904044 A GB 0904044A GB 0904044 D0 GB0904044 D0 GB 0904044D0
Authority
GB
United Kingdom
Prior art keywords
pain
treatment
inflammatory disorders
disorders
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0904044.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sosei R&D Ltd
Original Assignee
Arakis Ltd
Sosei R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd, Sosei R&D Ltd filed Critical Arakis Ltd
Priority to GBGB0904044.5A priority Critical patent/GB0904044D0/en
Publication of GB0904044D0 publication Critical patent/GB0904044D0/en
Priority to PCT/GB2010/050401 priority patent/WO2010103312A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0904044.5A 2009-03-09 2009-03-09 The treatment of inflammatory disorders and pain Ceased GB0904044D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0904044.5A GB0904044D0 (en) 2009-03-09 2009-03-09 The treatment of inflammatory disorders and pain
PCT/GB2010/050401 WO2010103312A1 (en) 2009-03-09 2010-03-09 Hydroxymorpholiness and their use for the treatment of inflammatory disorders and pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0904044.5A GB0904044D0 (en) 2009-03-09 2009-03-09 The treatment of inflammatory disorders and pain

Publications (1)

Publication Number Publication Date
GB0904044D0 true GB0904044D0 (en) 2009-04-22

Family

ID=40600757

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0904044.5A Ceased GB0904044D0 (en) 2009-03-09 2009-03-09 The treatment of inflammatory disorders and pain

Country Status (2)

Country Link
GB (1) GB0904044D0 (en)
WO (1) WO2010103312A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
FR2564462B1 (en) * 1984-05-16 1986-11-21 Lafon Labor 2-PHENYL-MORPHOLINE DERIVATIVES USEFUL IN THERAPEUTICS
DE10053275A1 (en) * 2000-10-27 2002-05-02 Dresden Arzneimittel New 7-aza-indole-3-carboxamides or glyoxylamides, useful e.g. for treating rheumatoid arthritis, osteoporosis, sepsis, asthma or multiple sclerosis are phosphodiesterase-4 and tumor necrosis factor-alpha inhibitors
US6653346B1 (en) * 2002-02-07 2003-11-25 Galileo Pharmaceuticals, Inc. Cytoprotective benzofuran derivatives
WO2008026046A1 (en) * 2006-08-30 2008-03-06 Pfizer Products Inc. Morpholine d3 dopamine antagonists
GB0700786D0 (en) * 2007-01-15 2007-02-21 Pfizer Ltd Morpholine dopamine agonists for the treatment of pain

Also Published As

Publication number Publication date
WO2010103312A1 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
HRP20190059T1 (en) Compositions for the treatment of pain and/or inflammation
GB0904044D0 (en) The treatment of inflammatory disorders and pain
IL217901A0 (en) Treatment of bdnf-related disorders using laquninimod
EP2552433A4 (en) Compositions and methods for the treatment of somatosensory disorders
HK1168091A1 (en) Oxazine derivatives and their use in the treatment of neurological disorders
HK1166305A1 (en) Compositions and methods for the treatment of inflammation
EP2387407A4 (en) Medicament for the treatment of pain and inflammation
EP2575824A4 (en) Methods for the treatment and prevention of inflammatory diseases
HUE042736T2 (en) Managing the treatment of inflammatory or autoimmune disorders using hom-1 expression
EP2488198A4 (en) Treatment and diagnosis of inflammatory disorders
IL215990A0 (en) Phosphotetrahydfropyran compounds for the treatment of wounds and fibrotic disorders
HK1179523A1 (en) N-substituted benzenepropanamide or benzenepropenamide for use in the treatment of pain and inflammation n-
IL193943A0 (en) The use of beta- aminoalcohols for the treatment of inflammatory disorders and pain
IL223385B (en) Treatment of inflammatory disorders
GB0604822D0 (en) The treatment of inflammatory disorders and pain
GB0817330D0 (en) The treatment of inflammatory disorders and pain
GB0803397D0 (en) The treatment of inflammatory disorders and pain
GB0819446D0 (en) Treatment of inflammatory disorders
AP2779A (en) Treatment of CNS and pain disorders
GB0814043D0 (en) The treatment of skin disorders
HK1145282A1 (en) Treatment of sleep disorders
GB0722524D0 (en) The treatment of inflammatory disorders and pain
GB0718279D0 (en) The treatment of inflammatory disorders and pain
GB0711769D0 (en) The treatment of inflammatory disorders and pain
GB0703494D0 (en) The treatment of inflammatory disorders and pain

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)